Deaths decline in early stage cancer drug trials
In 1991–2002, 35 drug related deaths occurred across 213 Phase I trials involving 6,474 patients, with deaths dropping from 24 in 1991–1994 to 1 in 1999–2002 as safety oversight grew. Non drug related cancer deaths also fell from 39 to 17, while tumor shrinkage rates rose modestly amid newer targeted therapies. Researchers credit stricter safety rules and more oversight for the improved outcomes.
Studies show safer cancer drugs in early human trials
A new study finds patient deaths in initial Phase I cancer drug trials fell sharply from 1991 to 2002. Safer outcomes are linked to targeted, less toxic therapies and tighter safety monitoring as trials focus on early stage disease and high-risk patients.
Flu shots curb elderly deaths says Dutch study
A Erasmus University study of 26 071 residents aged 65 and older from 1996 to 1999 found vaccination rates rose from 64 to 74 percent, with 5 095 never vaccinated. Researchers say annual flu shots significantly reduce deaths from all causes among the elderly.
MENTIONED IN THIS ARTICLE
Chicago
U.S
A.C.G. Woordouw
Erasmus University
Rotterdam
Netherlands
Also Mentioned on This Page
Mace Rothenberg
Vanderbilt University Cancer Research
Thomas Roberts Jr
Massachusetts General Hospital
Roberts
Journal of the American Medical Association
Aar
American Medical
Bosworth Company
Midland Odessa
Kerrville
Bosworthco.com
Orig
Foxton
Oxford
Tan
Gamma High
Dillard's
Dillard’s
Visa
Mastercard
American Express
Discover
Diners Club
Music City Mall